 LOS ANGELES--BUSINESS WIRE--- ACRX CLASSACTION--Glancy Prongay Murray LLP GPM, a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired AcelRx Pharmaceuticals, Inc. AcelRx or the Company NASDAQ: ACRX securities between March 17, 2020 and February 12, 2021, inclusive the Class Period. AcelRx investors have until August 9, 2021 to file a lead plaintiff motion. If you suffered a loss on your 